About this trial
This study investigates the correlation between ocular biological characteristics and overall conditions before and after liver transplantation by collecting ocular biological characteristics. Explore whether it is possible to construct a clinical prediction model for liver transplantation by incorporating ocular biometric features, in order to optimize disease management before and after liver transplantation.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age greater than or equal to 18 years old;
Late stage liver disease patients waiting for liver transplantation treatment, as well as patients with varying degrees of cirrhosis;
Can collect complete basic demographic information, liver function blood test indicators, liver pathology and imaging examination results;
Can cooperate with eye OCT, OCTA and other examinations, and obtain qualified examination parameters;
Disqualifiers
History of other organ transplant surgeries;
History of intraocular laser treatment, medication injection, and surgery;
History of high myopia, glaucoma, and retinal choroidal related eye diseases;
History of major systemic diseases other than liver disease;
Trial population
The liver transplant population was recruited from individuals who went to cooperative medical unit for liver transplant registration, while normal individuals were recruited from the project responsible unit.
Trial design
Cohort
Prospective
Treatments tested in this trial
Ophthalmic examination
Diagnostic testVarious ophthalmic examination modalities, including slit lamp photography, fundus photography, optical coherence tomography imaging and optical coherence tomography angiography, etc.
General Condition Examination
Diagnostic testVarious general condition examination, including blood pressure measurement, blood glucose testing, blood routine examination, coagulation function test, liver function test, etc.
Treatment groups
Trial outcomes
Primary outcomes
The performance of predicting the prognosis of liver transplantation
Based on the outcomes of early graft dysfunction and 1-year graft survival rate, the area under the receiver operating characteristic curve, specificity, and sensitivity of the model
Secondary outcomes
The performance of the model in assessing the severity of liver disease
The confusion matrix of the model based on the MELD score results
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Zhongshan Ophthalmic Center, Sun Yat-sen University
Lead sponsor
First Affiliated Hospital, Sun Yat-Sen University
Collaborator
Second Affiliated Hospital, Sun Yat-Sen University
Collaborator
Guangdong Provincial People's Hospital
Collaborator
Nanfang Hospital, Southern Medical University
Collaborator
Zhongshan People's Hospital, Guangdong, China
Collaborator
Guangdong Provincial People's Hospital, China
Collaborator
First People's Hospital of Foshan
Collaborator